DE NOVO ANTIBODY DESIGN
We develop the next generation of Antibody Therapeutics using Generative-AI
AT A GLANCE
Who we are
Silica Corpora is a Therapeutics Company aiming to provide the next generation of therapeutic Antibodies using Gen-AI.
Our proprietary AI platform, powered by proprietary Foundation Models for De Novo Antibody Design is capable of finding meaningful antibody candidates using only amino acid sequences.
​
We believe each project is different, and that is why we aim to work closely with our partners to build a shared pipeline.
WHY TO CHOOSE US
Find out why Silica Corpora is your best ally for Antibody Discovery
We want to grow with you.
Aside other CRO models, Silica Corpora wants to establish long-lasting partnerships to co-develop tailored and meaningful solutions. While being able to use all our existing tools, we use your accumulated data to create your tailored models and improve the quality of your future drug candidates.
OUR UNIQUENESS
A holistic approach to reach the next generation of drug development.
Taking advantage of the progress in Generative-AI, we developed a protein-LLM that works only with AA sequences, making the characterization stage much more agile.
Using AI models trained on amino acid sequences we can generate more quality Antibodies from scratch, without using In Vitro nor In Vivo Methods.